Friday 6 November 2026 Export CRL’s income statement to Excel — free account

Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024.

Revenue: −2.20%
EPS: +530.3%
Free cash flow: +16.3%
Total debt: +11.8%

Quarter to September 2026, against a year earlier

313.98 12.31 −3.77%

Follow CRL

Alert me

Market cap: $14.9B
P/E: 300×
Fwd P/E: 89.2×
Dividend yield: —
F-score: 5/9
Altman Z: 2.40
Beneish M: −3.11
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Charles River Laboratories International, Inc. (CRL) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Charles River Laboratories International, Inc. (CRL) trades at a P/E ratio of 300×. Over the past ten years it has ranged from 0.0× (September 2026) to 1,056× (January 2025); the current reading is higher than 98% of that period. That is above the Diagnostics & Research industry median of 34.5× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/CRL/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Charles River Laboratories International, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/CRL/metrics/pe-ratio">Charles River Laboratories International, Inc. (CRL) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	1,026×	3,954.06%
FY2023	25.3×	10.85%
FY2022	22.8×	(52.94%)
FY2021	48.5×	42.45%
FY2020	34.0×	15.21%
FY2019	29.5×	22.70%
FY2018	24.1×	(43.63%)
FY2017	42.7×	84.22%
FY2016	23.2×	(7.40%)

Period	P/E ratio	Change
Sep 2026	282×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
43 more quarters	Free account

Against its own ten years

Low 0.0× High 1,056×

Ten-year median 26.7×

Current reading's percentile 97

Company	P/E ratio
GH Guardant Health, Inc. compare	n/m
DGX Quest Diagnostics Incorporated compare	25.0×
QGEN QIAGEN N.V. compare	26.1×
LH Labcorp Holdings Inc. compare	29.5×
ICLR ICON PLC compare	34.5×
MEDP Medpace Holdings, Inc. compare	34.6×
ILMN Illumina, Inc. compare	35.6×
RVTY Revvity Inc. compare	71.9×
CRL Charles River Laboratories International, Inc.	300×
Diagnostics & Research industry median	34.5×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Charles River Laboratories International, Inc. (CRL) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on CRL

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on CRL

Stockrow Weekly